The CXCR4 antagonists, such as T140, FC131, CTCE9908 and AMD3100, can effectively block functional CXCR4 to intervene SDF-1/CXCR4-mediated tumor progression and metastasis [43, 44]. This evidence concerns the gene CXCL12 and neoplasm.